2025 HCPCS Code J7207
Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
TAGS: factor| Short Description | Factor viii pegylated recomb |
| Product Note | 0127 |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 2017 |
| HCPCS Action Effective Date | January 01, 2017 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J9298 - Inj nivol relatlimab 3mg/1mg
- J9299 - Injection, nivolumab
- J9300 - Gemtuzumab ozogamicin inj
- J9301 - Obinutuzumab inj
- J9302 - Ofatumumab injection
- J9303 - Panitumumab injection
- J9304 - Inj. pemetrexed, 10 mg
- J9305 - Inj. pemetrexed nos 10mg
- J9306 - Injection, pertuzumab, 1 mg
- J9307 - Pralatrexate injection
- J9308 - Injection, ramucirumab
- J9309 - Inj, polatuzumab vedotin 1mg
- J9310 - Rituximab injection
- J9311 - Inj rituximab, hyaluronidase
- J9312 - Inj., rituximab, 10 mg
- J9313 - Inj., lumoxiti, 0.01 mg
- J9314 - Inj pemetrexed (teva) 10mg
- J9315 - Romidepsin injection
- J9316 - Pertuzu, trastuzu, 10 mg
- J9317 - Sacituzumab govitecan-hziy